Literature DB >> 29937043

Mining Public Databases for Precision Oncology.

Jason Roszik1, Vivek Subbiah2.   

Abstract

Millions of dollars have been spent on creating public databases. To date these data reside in isolated 'silos'. Real-world realization of precision oncology, the right drug for the right patient at the right time, may be possible only if the right data come to the right clinic at the right time.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29937043     DOI: 10.1016/j.trecan.2018.04.008

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  5 in total

1.  Expression profile and prognostic values of STAT family members in non-small cell lung cancer.

Authors:  Mengqi Yang; Huanting Chen; Lin Zhou; Kai Chen; Fengxi Su
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

2.  Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome.

Authors:  Marwan Fakih; Ching Ouyang; Chongkai Wang; Travis Yiwey Tu; Maricel C Gozo; May Cho; Marvin Sy; Jeffrey A Longmate; Peter P Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

3.  MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.

Authors:  Anthony P Conley; Wei-Lien Wang; John A Livingston; Vinod Ravi; Jen-Wei Tsai; Ali Ali; Davis R Ingram; Caitlin D Lowery; Christina L Roland; Neeta Somaiah; Patrick Hwu; Cassian Yee; Vivek Subbiah; Andrew Futreal; Alexander J Lazar; Shreyaskumar Patel; Jason Roszik
Journal:  Cancers (Basel)       Date:  2019-05-15       Impact factor: 6.639

Review 4.  Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics.

Authors:  Carlos D Vera; Angela Zhang; Paul D Pang; Joseph C Wu
Journal:  Front Cardiovasc Med       Date:  2022-03-10

5.  Gene Expression Analysis Identifies Novel Targets for Cervical Cancer Therapy.

Authors:  Jason Roszik; Kari L Ring; Khalida M Wani; Alexander J Lazar; Anna V Yemelyanova; Pamela T Soliman; Michael Frumovitz; Amir A Jazaeri
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.